Clinical Trials Arena May 21, 2024
Jenna Philpott

Heartbeam AI plus VCG outperformed an expert panel of three cardiologists by 40% in detecting atrial flutter.

HeartBeam has presented data demonstrating that its HeartBeam AI applied to vectorcardiography (VCG) technology outperformed an expert panel of heart rhythm cardiologists in detecting atrial flutter.

The data, presented at the Heart Rhythm Society Conference in Boston, US, showed that the HeartBeam AI and VCG (HeartBeam AI+VECG) combination significantly outperformed an expert panel in detecting atrial flutter. It had a 97.3% sensitivity compared to 69.4% for the panel using single-lead electrocardiograms (ECGs) – demonstrating a 40% improvement. It also showed a 6% improvement over the panel using 12-lead ECGs.

The US-based company announced that it had made significant advancements to its...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Medical Devices, Provider, Technology
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3
State Licensing Spotlight - Prescription medical device manufacturers & distributors: Regulatory considerations applicable to medical devices versus drugs
Boston Scientific to buy Sonivie for up to $540M

Share This Article